121 related articles for article (PubMed ID: 38527714)
21. Association of C4d deposition with clinical outcomes in IgA nephropathy.
Espinosa M; Ortega R; Sánchez M; Segarra A; Salcedo MT; González F; Camacho R; Valdivia MA; Cabrera R; López K; Pinedo F; Gutierrez E; Valera A; Leon M; Cobo MA; Rodriguez R; Ballarín J; Arce Y; García B; Muñoz MD; Praga M;
Clin J Am Soc Nephrol; 2014 May; 9(5):897-904. PubMed ID: 24578331
[TBL] [Abstract][Full Text] [Related]
22. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
[TBL] [Abstract][Full Text] [Related]
23. Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
Lin Z; Liu L; Zhang R; Lin X; Lu F; Bao K; Wang L; Lin Q; Mai J; Cao Y; Yang H; Liu X; Zou C
Am J Nephrol; 2021; 52(6):507-518. PubMed ID: 34134110
[TBL] [Abstract][Full Text] [Related]
24. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
Wu H; Fang X; Xia Z; Gao C; Peng Y; Li X; Zhang P; Kuang Q; Wang R; Wang M
J Nephrol; 2020 Dec; 33(6):1263-1273. PubMed ID: 32507961
[TBL] [Abstract][Full Text] [Related]
25. Clinical Significance of Crescent Formation in IgA Nephropathy - a Multicenter Validation Study.
Park S; Baek CH; Park SK; Kang HG; Hyun HS; Park E; Han SH; Ryu DR; Kim DK; Oh KH; Joo KW; Kim YS; Moon KC; Chin HJ; Lee H
Kidney Blood Press Res; 2019; 44(1):22-32. PubMed ID: 30808840
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D deficiency may predict a poorer outcome of IgA nephropathy.
Li XH; Huang XP; Pan L; Wang CY; Qin J; Nong FW; Luo YZ; Wu Y; Huang YM; Peng X; Yang ZH; Liao YH
BMC Nephrol; 2016 Nov; 17(1):164. PubMed ID: 27806690
[TBL] [Abstract][Full Text] [Related]
27. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
Jiang Z; Tan J; Wang S; Dong L; Han X; Tang Y; Qin W
Int J Med Sci; 2021; 18(13):2964-2970. PubMed ID: 34220324
[No Abstract] [Full Text] [Related]
28. Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study.
Pan M; Zhou Q; Zheng S; You X; Li D; Zhang J; Chen C; Xu F; Li Z; Zhou Z; Zhang J
Immunol Res; 2018 Jun; 66(3):381-391. PubMed ID: 29850970
[TBL] [Abstract][Full Text] [Related]
29. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
[TBL] [Abstract][Full Text] [Related]
30. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 33741175
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
[TBL] [Abstract][Full Text] [Related]
32. Renal Megalin mRNA Downregulation Is Associated with CKD Progression in IgA Nephropathy.
Wen L; Wang X; Ji F; Wen J; Zhao Z
Am J Nephrol; 2022; 53(6):481-489. PubMed ID: 35661648
[TBL] [Abstract][Full Text] [Related]
33. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
[TBL] [Abstract][Full Text] [Related]
35. Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
Kataoka H; Ohara M; Suzuki T; Inoue T; Akanuma T; Kawachi K; Manabe S; Ushio Y; Kawasoe K; Akihisa T; Sato M; Iwasa N; Sawara Y; Honda K; Mochizuki T; Tsuchiya K; Nitta K
PLoS One; 2020; 15(5):e0232885. PubMed ID: 32379841
[TBL] [Abstract][Full Text] [Related]
36. Cigarette smoking may accelerate the progression of IgA nephropathy.
Wang S; Qin A; Pei G; Jiang Z; Dong L; Tan J; Tan L; Tang Y; Qin W
BMC Nephrol; 2021 Jun; 22(1):239. PubMed ID: 34187402
[TBL] [Abstract][Full Text] [Related]
37. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
[TBL] [Abstract][Full Text] [Related]
38. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
Zhang J; Wang C; Tang Y; Peng H; Ye ZC; Li CC; Lou TQ
Nephrology (Carlton); 2013 Feb; 18(2):125-31. PubMed ID: 23134230
[TBL] [Abstract][Full Text] [Related]
39. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]